Probably less selling pressure as most traders, investors, etc are leaving for this holiday season.
They should be back on 4/1/2021

I think the best valuation for glove counters is post Covid-19 and after 2024 where demand is expected normalise, though still much higher then pre-Covid-19.
My take is pre-covid-19 , world demand is approximately 260 bil per annum in 2019
Post Covid-19, world demand should be somewhere between 350 bil to 370 bil per annum in 2024 onwards.

Supply side by 2024 from Top 5 largest and small players worldwide may come in between 110-130 bil per annum.

Based on this estimation, demand will almost offset the large incoming supply in 4 years time. Possible small oversupply of 20bil-25 bil per annum which may cause ASP to normalise toward USD35-USD45 level which is 50%-80% higher pre-covid 19 ASP.

I disagree.
I believe charting is as important as financial analysis.
Using both method yielded impressive results for me.

@gongkia

https://klse.i3investor.com/blogs/koonyewyinblog/2020-11-17-story-h1536464770-Supermax_is_the_most_underrated_glove_stock_Koon_Yew_Yin.jsp

Average price of supermax on 16/11/2020 is RM8, 1 day before he post this blog

KYY re-entered price is above RM8.
He's making losses already.

I still don't get it why ppl are still debating on glove vs vaccine, sell or buy glove.

Get a life all of you.

Know your investment principle that had been perfected, ignore the noises, buy or sell whatever stock as you see fit.

No justification required because you are the specialist in your investment.

At the end of the day, your portfolio grows or shrinks, look at yourself in the MIRROR, the answer lies there.

Buy a stock based on your understanding not from others.
Learn to do your own valuation and be good at it.
Prove to others than you do not require to follow the herd.
Buy or sell at your own judgement as it is your own hard earned money.
Unless somehow, you received a large donation of USD600 mil.

Not a glove maker yet

'To be' glove maker

@KYY
Higher EPS of Supermax does not mean, the company is better than Hartalega , Topglove or Kossan.

Factors such as no of share issued is also a consideration. Topglove issued more shares which has a larger denominator than Supermax, thus the lower EPS.
If Topglove has the same no of shares issued as Supermax, the current EPS would be more than RM1.0.

Rather the focus should be the company's annual net profit

Actually back then before CNY 2020, Supermax was trading at lower PE of 12 as compared its peers: Topglove (pe=30), Kossan (pe=25), Harta (pe=45)

It's more like investor began to see that it's undervalued and the PE now is reflecting better than previously.

Define better?

1QFY2021 will be released on 09 December 2020

https://www.topglove.com/corporate-calendar/

Topglove: What will Topglov be reporting Q3 profit?


https://klse.i3investor.com/blogs/20200913StoryRM200Bil/2020-11-18-story-h1536493634-Topglove_What_will_Topglov_be_reporting_Q3_profit.jsp

Topglove: What will Topglov be reporting Q3 profit?


https://klse.i3investor.com/blogs/20200913StoryRM200Bil/2020-11-18-story-h1536493634-Topglove_What_will_Topglov_be_reporting_Q3_profit.jsp

Topglove: What will Topglov be reporting Q3 profit?


https://klse.i3investor.com/blogs/20200913StoryRM200Bil/2020-11-18-story-h1536493634-Topglove_What_will_Topglov_be_reporting_Q3_profit.jsp

Topglove: What will Topglov be reporting Q3 profit?


https://klse.i3investor.com/blogs/20200913StoryRM200Bil/2020-11-18-story-h1536493634-Topglove_What_will_Topglov_be_reporting_Q3_profit.jsp

Topglove: What will Topglov be reporting Q3 profit?


https://klse.i3investor.com/blogs/20200913StoryRM200Bil/2020-11-18-story-h1536493634-Topglove_What_will_Topglov_be_reporting_Q3_profit.jsp

for those in 10th floor, I suggest keep the stock, enjoy the company's large expansion to 40++ bil glove production in 2 years, get rewarded with dividends and bonus issues in the future if you believe the company's long term growth.

Unless, you have desperate need to use the money you had put into this counter.

Good write up.
Simple and on the spot.
It's really up to individual investor to decide their entry & exit.
Long term investors > 5 years normally do well.

Unlike KYY who is not an investor as he seems more like a trader which I do not recommend as there is volatility in the short term nature of glove stocks and pharma stocks.

Whoever prefers to buy vaccine, buy pharma related counters
Whoever prefer gloves, buy glove counters.
Whoever think both are good, buy both pharma and gloves
Whoever think both are over, sell everything

I don't see the point of arguing over it.

Topglove had updated the CBP status in the annual report on 12/11.

Dividends had been declared on 23/9 and paid on 3/11.

Which part you are not clear?

https://de.reuters.com/article/us-health-coronavirus-vaccines-distribut/why-pfizers-ultra-cold-covid-19-vaccine-will-not-be-at-the-local-pharmacy-any-time-soon-idUSKBN27P2VI

Pfizer vaccine needs to be at minus 70-80 degrees celcius

Yusen Gold Cold can handled up to minus 20 degrees celcius


https://www.yusen-logistics.com/en/industries/healthcare-logistics/

Our capabilities include dedicated and managed fleets with temperature-control capabilities and secure GDP compliant temperature controlled hubs. These controlled temperature (15–25°C), cold storage (2–8°C) and frozen storage (<–20°C) facilities allow us to offer warehouse capacity for a range of pharmaceutical and biopharmaceutical products.

https://de.reuters.com/article/us-health-coronavirus-vaccines-distribut/why-pfizers-ultra-cold-covid-19-vaccine-will-not-be-at-the-local-pharmacy-any-time-soon-idUSKBN27P2VI

Pfizer vaccine needs to be at minus 70-80 degrees celcius

Yusen Gold Cold can handled up to minus 20 degrees celcius


https://www.yusen-logistics.com/en/industries/healthcare-logistics/

Our capabilities include dedicated and managed fleets with temperature-control capabilities and secure GDP compliant temperature controlled hubs. These controlled temperature (15–25°C), cold storage (2–8°C) and frozen storage (<–20°C) facilities allow us to offer warehouse capacity for a range of pharmaceutical and biopharmaceutical products.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3097777

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3097777

Expected this to happne when you rush to develop this vaccine in 6 months which normally takes at least 2-3 years and some 4-5 years.

I'm fairly confident that after the vaccine is developed, very few ppl will want to be vaccinated as they are afraid of the unknown adverse affects of it.

Just like software release of Alpha/Beta version, most ppl would wait for the official release.

Ask yourself a question where Supermax will be 10 years from now.

@Steve Ooi

It's President Biden's mandate during his election campaign to procure PPE using his Executive Order.

https://www.cnbc.com/2020/10/23/joe-biden-lays-out-a-detailed-plan-to-fight-coronavirus-.html

@Airline Bobby

You're another individual negative of glove based on all your comments.
I'm publishing based on facts and I did not give a timeline as no one knows.

One key point for sure is WRP Asia case took 6 months to revoke, thus is a good benchmark since Topglove had engaged the same consultant that helps WRP Asia to solve the same issue.

@limkt88
You only have 7 comments and mostly negative towards glove.
CBP is enforced by customs department and is govern by the executive order of the President of United States of America.

With new president in placed, commissioner's office will likely be replaced with Biden's team.

Topglove: New president Biden will bring changes to US CBP decision


https://klse.i3investor.com/blogs/20200913StoryRM200Bil/2020-11-08-story-h1535688373-Topglove_New_president_Biden_will_bring_changes_to_US_CBP_decision.jsp

Topglove: New president Biden will bring changes to US CBP decision


https://klse.i3investor.com/blogs/20200913StoryRM200Bil/2020-11-08-story-h1535688373-Topglove_New_president_Biden_will_bring_changes_to_US_CBP_decision.jsp

Topglove: New president Biden will bring changes to US CBP decision


https://klse.i3investor.com/blogs/20200913StoryRM200Bil/2020-11-08-story-h1535688373-Topglove_New_president_Biden_will_bring_changes_to_US_CBP_decision.jsp

Topglove: New president Biden will bring changes to US CBP decision


https://klse.i3investor.com/blogs/20200913StoryRM200Bil/2020-11-08-story-h1535688373-Topglove_New_president_Biden_will_bring_changes_to_US_CBP_decision.jsp

Topglove: New president Biden will bring changes to US CBP decision


https://klse.i3investor.com/blogs/20200913StoryRM200Bil/2020-11-08-story-h1535688373-Topglove_New_president_Biden_will_bring_changes_to_US_CBP_decision.jsp

Topglove: New president Biden will bring changes to US CBP decision


https://klse.i3investor.com/blogs/20200913StoryRM200Bil/2020-11-08-story-h1535688373-Topglove_New_president_Biden_will_bring_changes_to_US_CBP_decision.jsp

Topglove: New president Biden will bring changes to US CBP decision


https://klse.i3investor.com/blogs/20200913StoryRM200Bil/2020-11-08-story-h1535688373-Topglove_New_president_Biden_will_bring_changes_to_US_CBP_decision.jsp

KYY is re-writing and re-producing old data.
The 1st slides is like 4-5months old.
There are newer data already out on Supermax in October.
Is there something wrong with him?

To be honest, Monday should be positive for glove stocks as most industry experts are looking at least RM2.4 billion for extraordinary profit taxation.

With no windfall taxation lingering, most investors have peace of mind till 2022 and beyond.

https://themalaysianreserve.com/2020/11/04/glove-industry-to-pay-higher-corporate-taxes-says-no-to-windfall-tax/

Expecting monday to move closer to RM9 and above in view of positive outcome from Budget 2021 and Covid-19 negative outlook worldwide.

KUALA LUMPUR (Nov 6): Top Glove Corp Bhd, Hartalega Holdings Bhd and Supermax Corp Bhd have confirmed that they are donating to the Government’s COVID-19 fund set up to battle the pandemic.

When contacted by theedgemarkets.com, Top Glove said it is donating RM185 million to the fund, while Supermax will be chipping in RM75 million.

Meanwhile, Hartalega said in a statement that it will be contributing RM90 million to the fund.

“This is a corporate social responsibility initiative by Hartalega to make a positive difference in the lives of Malaysians and support the nation’s healthcare sector,” it said.

Their total contributions amount to RM350 million.

This follows the tabling of Budget 2021 this afternoon, whereby Finance Minister Tengku Datuk Seri Zafrul Aziz announced that that the three glove makers, in addition to Kossan Rubber Industries Bhd, have committed to donate RM400 million to the COVID-19 fund.

The money will be used to cover part of the cost of vaccines and health equipment expenses, said the Minister.

https://www.theedgemarkets.com/article/top-glove-hartalega-and-supermax-confirm-donations-govts-rm400-mil-covid19-fund

the breakdown does not have a proper source?

Budget 2021: Top Glove, other rubber glove manufacturers pledge RM400m to assist Covid-19 fight, including for vaccines

A small contribution to the society should be applause, NO WINDFALL TAX

Topglove is more transparent with their orderbook than supermax as the company indicates the exact month and year. So that investor will be assured.

Topglove: Overwhelming Demand For Nitrile Glove

https://klse.i3investor.com/blogs/20200913StoryRM200Bil/2020-11-05-story-h1535632544-Topglove_Overwhelming_Demand_For_Nitrile_Glove.jsp

Topglove: Overwhelming Demand For Nitrile Glove

https://klse.i3investor.com/blogs/20200913StoryRM200Bil/2020-11-05-story-h1535632544-Topglove_Overwhelming_Demand_For_Nitrile_Glove.jsp

Topglove: Overwhelming Demand For Nitrile Glove

https://klse.i3investor.com/blogs/20200913StoryRM200Bil/2020-11-05-story-h1535632544-Topglove_Overwhelming_Demand_For_Nitrile_Glove.jsp

Topglove: Overwhelming Demand For Nitrile Glove

https://klse.i3investor.com/blogs/20200913StoryRM200Bil/2020-11-05-story-h1535632544-Topglove_Overwhelming_Demand_For_Nitrile_Glove.jsp

Topglove: Overwhelming Demand For Nitrile Glove

https://klse.i3investor.com/blogs/20200913StoryRM200Bil/2020-11-05-story-h1535632544-Topglove_Overwhelming_Demand_For_Nitrile_Glove.jsp

Topglove: Overwhelming Demand For Nitrile Glove


https://klse.i3investor.com/blogs/20200913StoryRM200Bil/2020-11-05-story-h1535632544-Topglove_Overwhelming_Demand_For_Nitrile_Glove.jsp